70 Results for "

CB1 antagonists

" in MedChemExpress (MCE) Product Catalog:
Products (70)

70 Results for "CB1 antagonists" in MCE Product Catalog:

26
26 Publications Verification
Cat. No.: HY-15443
CAS No.: 183232-66-8
Purity:  99.09%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM. AM251 also acts as a potent GPR55 agonist with an EC50 of 39 nM .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-14136
CAS No.: 168273-06-1
Purity:  99.18%
Synonyms: SR141716
Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with a Ki of 1.8 nM. Rimonabant (SR141716) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-14137
CAS No.: 158681-13-1
Purity:  99.31%
Synonyms: SR 141716A Hydrochloride
Rimonabant Hydrochloride (SR 141716A Hydrochloride) is a highly potent and selective central cannabinoid receptor (CB1) antagonist with an Ki of 1.8 nM. Rimonabant Hydrochloride (SR 141716A Hydrochloride) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-18697
CAS No.: 1392116-14-1
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease Cancer

JD-5037 is a potent CB1R antagonist with an IC50 of 1.5 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10871
CAS No.: 686344-29-6
Purity:  99.23%
Synonyms: CP-945598
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

Otenabant is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110125
CAS No.: 713121-80-3
Purity:  99.82%
Synonyms: CID 1261822
Target:  

GPR55

Research Areas:  

Neurological Disease

ML-193 (CID 1261822) is a potent and selective antagonist of GPR55, with an IC50 of 221 nM. ML-193 shows more than 27-fold selectivity for GPR55 over GPR35, CB1 and CB2. ML-193 can improve the motor and the sensorimotor deficits of Parkinson’s disease (PD) rats .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1161A
CAS No.: 65733-16-6
Synonyms: (+)-Methoprene; (7S)-Methoprene
Research Areas:  

Others

S-Methoprene is an insect juvenile hormone analog and effective insecticide that blocks the transition from pupa to adult. S-Methoprene is also a CB(1) receptor ligand and inhibits the binding of the CB1 receptor antagonist [ 3H]CP-55940 to the CB1 receptor (IC50: 19.31 μM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153800
CAS No.: 2712480-46-9
Purity:  99.97%
Synonyms: (S)-MRI-1891; INV-202
Research Areas:  

Metabolic Disease

Monlunabant ((S)-MRI-1891) is an orally active antagonist for cannabinoid receptor 1 (CB1), binds to hCB1 and hCB2 with Ki of 0.3 nM and 613 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13505
CAS No.: 202463-68-1
Purity:  98.60%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM281 is a selective CB1 receptor antagonist with an IC50 of 9.91 nM. AM281 inhibits CB2 receptor with an IC50 of 13000 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116649
CAS No.: 614726-85-1
Purity:  99.91%
Synonyms: AM4113
CB1 antagonist 2 (AM4113) is an orally active cannabinoid receptor type 1 (CB1R) antagonist. CB1 antagonist 2 suppresses appetite, reduces body weight, and blocks addictive behaviors such as heroin addiction, without causing adverse effects like nausea and depression that are associated with traditional CB1 inverse agonists. CB1 antagonist 2 can be used in studies related to obesity and opioid addiction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14791A
CAS No.: 362519-49-1
Purity:  99.30%
Synonyms: (±)-SLV319; (±)-BMS-646256
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

(±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14791
CAS No.: 464213-10-3
Purity:  99.90%
Synonyms: SLV319; BMS-646256
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

Ibipinabant (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. Ibipinabant shows more than 1000-fold selectivity for CB1 over CB2 (Ki=7943 nM). Ibipinabant can be used for the research of obesity and diabetic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117139
CAS No.: 494844-07-4
Purity:  99.22%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

NESS 0327 is a cannabinoid antagonist with high selectivity for the cannabinoid CB1 receptor. NESS 0327 is more than 60,000-fold selective for the CB1 receptor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103335
CAS No.: 536697-79-7
Purity:  96.60%
Target:  

Cannabinoid Receptor

Research Areas:  

Cardiovascular Disease

O1918 is a selective non-CB1 receptor and GPR18 antagonist.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6932
CAS No.: 3371-85-5
Voacamine is an indole alkaloid with cannabinoid 1 (CB1) antagonistic activity. Voacamine can inhibit nuclear translocation. Voacamine is effective in enhancing the effect of Doxorubicin (HY-15142A) as it interferes with the P-glycoprotein (P-gp) function. Voacamine promotes apoptosis-independent autophagic cell death in human osteosarcoma cells. Voacamine activates mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway to suppress breast cancer progression. Voacamine inhibits EGFR to exert oncogenic activity against colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121827
CAS No.: 611207-11-5
Purity:  99.83%
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

LH-21 is a potent in vivo neutral cannabinoid CB1 receptor antagonist. LH-21 reduces food intake and body weight gain in obese Zucker rats. , and displays efficacy as a feeding inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141411
CAS No.: 1610420-28-4
Purity:  99.20%
Synonyms: (Rac)-MRI-1867
Research Areas:  

Others

(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis .
loading...
    loading...
Cat. No.: HY-116637
CAS No.: 20601-85-8
Purity:  99.79%
Synonyms: Magnolignan
Tetrahydromagnolol (Magnolignan), the main metabolite of Magnolol, is a potent and selective cannabinoidCB2 receptor agonist (EC50 =170 nM) and GPR55 antagonist. The Ki of Tetrahydromagnolol for CB2 is 416 nM, 20-fold higher than for the CB1 receptor. Magnolol shows antifungal, anti-inflammatory and analgesic effects .
loading...
    loading...
Cat. No.: HY-112340
CAS No.: 1253641-65-4
Purity:  99.00%
CB1 antagonist 4 (compound 8) is a selective cannabinoid receptor 1 (CB1) inverse agonist with an IC50 of 8.5 nM for human CB1. CB1 antagonist 4 shows selective for CB1 over CB2 receptors (IC50 of 604.9 nM). CB1 antagonist 4 inhibits GTP binding to CB1-overexpressing cell membranes with an EC50 of 18.5 nM .
loading...
    loading...
Cat. No.: HY-110206
CAS No.: 1245626-05-4
Purity:  99.32%
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

AM6545 is a highly selective, brain-free (peripherally active) CB1 receptor antagonist (Ki=1.7 nM). AM6545 inhibits endocannabinoid signaling by competitively antagonizing CB1 receptors, inhibiting CB1-mediated appetite stimulation and inflammatory responses without affecting cAMP levels. AM6545 significantly reduces food intake and body weight in mice, while improving metabolic syndrome-related renal impairment (such as proteinuria, fibrosis) and insulin resistance. AM6545 can be used in the study of obesity and its complications .
loading...
    loading...